Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Releases Quarterly Earnings Results

Greenland Mines Ltd. Common Stock (NASDAQ:GRML – Get Free Report) announced its earnings results on Monday. The company reported ($2.51) EPS for the quarter, Zacks reports.

Greenland Mines Ltd. Common Stock Trading Down 0.3%

NASDAQ:GRML traded down $0.01 during trading hours on Monday, reaching $3.60. The company had a trading volume of 262,312 shares, compared to its average volume of 2,655,898. The firm has a market cap of $49.28 million, a price-to-earnings ratio of -0.31 and a beta of 6.57. Greenland Mines Ltd. Common Stock has a 52 week low of $2.82 and a 52 week high of $36.99. The firm’s 50 day moving average price is $6.13 and its 200-day moving average price is $14.16.

Greenland Mines Ltd. Common Stock declared that its board has initiated a stock repurchase plan on Tuesday, October 6th that allows the company to buy back $20 million in shares. This repurchase authorization allows the company to repurchase up to 20.4% of its stock through open market purchases. Share repurchase plans are often an indication that the company’s leadership believes its shares are undervalued.

Insider Buying and Selling at Greenland Mines Ltd. Common Stock

In related news, Director Riad Hussein El-Dada sold 3,500 shares of the firm’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $9.35, for a total value of $32,725.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jeff Leblanc bought 14,000 shares of the business’s stock in a transaction dated Tuesday, August 25th. The shares were bought at an average cost of $9.72 per share, for a total transaction of $136,080.00. Following the transaction, the chief financial officer owned 110,406 shares in the company, valued at approximately $1,073,146.32. The trade was a 14.52% increase in their position. The SEC filing for this purchase provides additional information. Corporate insiders own 11.30% of the company’s stock.

Wall Street Analyst Weigh In

GRML has been the subject of several recent analyst reports. Wall Street Zen downgraded shares of Greenland Mines Ltd. Common Stock from a “sell” rating to a “strong sell” rating in a research report on Saturday, November 7th. Weiss Ratings downgraded shares of Greenland Mines Ltd. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, October 9th. One analyst has rated the stock with a Sell rating. According to MarketBeat.com, Greenland Mines Ltd. Common Stock has an average rating of “Sell”.

Check Out Our Latest Stock Report on Greenland Mines Ltd. Common Stock

Greenland Mines Ltd. Common Stock Company Profile

(Get Free Report)

Klotho Neurosciences, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan’s Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases.

Featured Stories

Earnings History for Greenland Mines Ltd. Common Stock (NASDAQ:GRML)

Receive News & Ratings for Greenland Mines Ltd. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Greenland Mines Ltd. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.